Management of Internal Carotid Artery and Intracranial Anterior Circulation Tandem Occlusion with Stenting versus No Stenting: A Multicenter Study

• Published in: World neurosurgery Vol. 153; pp. e237 - e243
• Main Authors: Gigliotti, Michael J., Sweid, Ahmad, El Naamani, Kareem, Patel, Neel, Cockroft, Kevin M., Park, Christian, Kanekar, Sangam, Church, Ephraim W., Tjoumakaris, Stavropoula I., Simon, Scott D.
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.09.2021
• Subjects: Acute ischemic stroke; Angioplasty; Carotid artery stent; Mechanical thrombectomy; Outcomes; Tandem occlusions; NIHSS; OR; tPA; Angioplasty; CI; ICA; MT; CSMT; AIS; Outcomes; sICH; mRS; Carotid artery stent; Tandem occlusions; Acute ischemic stroke; Mechanical thrombectomy; CAMT; TO
• ISSN: 1878-8750; 1878-8769
• DOI: 10.1016/j.wneu.2021.06.081

Tandem occlusion (TO) describes not only occlusion of the middle cerebral artery but a contemporaneous occlusion of the cervical internal carotid artery. There is a paucity of data over whether mechanical thrombectomy (MT) alone, MT with angioplasty, or MT with carotid artery stent placement is superior. We aim to address a gap in the literature comparing carotid stenting with mechanical thrombectomy (CSMT) and carotid angioplasty with mechanical thrombectomy (CAMT) in patients presenting with acute anterior circulation TOs. This is a multicenter, retrospective study from 2012 to 2020 comparing CSMT and CAMT presenting with acute anterior circulation TOs. Primary outcomes of interest were functional status, perioperative stroke, mortality, and symptomatic intracranial hemorrhage (sICH). A total of 92 patients (66 vs. 26 in CSMT and CAMT, respectively) met inclusion criteria for analysis. There was no statistically significant difference in functional outcomes at 90-day follow-up (adjusted odds ratio [aOR] 0.82; 95% confidence interval [CI] 0.20–3.5; P = 0.46). In addition, there was no statistically significant difference in 90-day mortality (aOR 0.361; 95% CI 0.016–2.92; P = 0.532) and perioperative stroke rate (aOR 1.76; 95% CI 0.160–15.6; P = 0.613). However, sICH risk was significantly greater in the stent-treated cohort (aOR 3.94; 95% CI 0.529–37.4; P = 0.003). Functional outcomes, mortality, and perioperative stroke rates do not significantly differ in CSMT and CAMT procedures in the acute setting. However, CSMT-treated patients do appear to have an increased risk of sICH, potentially due to the use of additional antiplatelet agents following stent placement.